Terms ending in 2034
Every in-force patent on Prime Merger Sub, LLC's record whose computed term ends in 2034, whoever holds it now. Soonest term end first, then patent number.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Holder | Status | Expires | Confidence |
|---|---|---|---|---|---|
| US 9,511,119 | Preparations Containing Hepatocyte Growth Factor and Hyaluronic Acid and Methods of Making and Using Same In force · High confidence | Prime Merger Sub, LLC | In force | High confidence | |
| US 10,279,075 | Preparations Containing Hepatocyte Growth Factor and Hyaluronic Acid, and Methods of Making and Using Same In force · Low confidence | Prime Merger Sub, LLC | In force | Low confidence | |
| US 9,700,585 | Multipotent Prenatal Stem Cells In force · High confidence | Prime Merger Sub, LLC | In force | High confidence |
3 of 3 patents shown. Soonest term end first, then patent number.
Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.